NCT03680612 - Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

February 14, 2018

Study Completion Date

February 14, 2018

Conditions

Urinary Tract Infections

Interventions

DRUG

Cefepime 1G - 2G / AAI101 0.5G - 0.75G

Experimental drug

DRUG

cefepime 1 g or cefepime 2 g

cefepime monotherapy

Trial Locations (5)

1204

Jahn Ferenc Del-pesti Korhaz, Budapest

14034

Chernihiv City Hospital #2 of Chernihiv City Council, department of Urology, Chernihiv

76701

Kromerizska nemocnice, Kroměříž

02-507

Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji w Warszawie, Klinika Chorob Wewnetrznych, Nefrologii i Transplantologii, Warsaw

081 81

Fakultna nemocnica s poliklinikou J.A. Reimana Presov, Prešov